NM_001281740.3:c.511+27649C>T

Variant summary

Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1

The NM_001281740.3(FHOD3):​c.511+27649C>T variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0658 in 152,228 control chromosomes in the GnomAD database, including 526 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.

Frequency

Genomes: 𝑓 0.066 ( 526 hom., cov: 32)

Consequence

FHOD3
NM_001281740.3 intron

Scores

2

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 0.363

Publications

4 publications found
Variant links:
Genes affected
FHOD3 (HGNC:26178): (formin homology 2 domain containing 3) The protein encoded by this gene is a member of the diaphanous-related formins (DRF), and contains multiple domains, including GBD (GTPase-binding domain), DID (diaphanous inhibitory domain), FH1 (formin homology 1), FH2 (formin homology 2), and DAD (diaphanous auto-regulatory domain) domains. This protein is thought to play a role in actin filament polymerization in cardiomyocytes. Mutations in this gene have been associated with dilated cardiomyopathy (DCM), characterized by dilation of the ventricular chamber, leading to impairment of systolic pump function and subsequent heart failure. Increased levels of the protein encoded by this gene have been observed in individuals with hypertrophic cardiomyopathy (HCM). Alternative splicing results in multiple transcript variants encoding different isoforms. A muscle-specific isoform has been shown to possess a casein kinase 2 (CK2) phosphorylation site at the C-terminal end of the FH2 domain. Phosphorylation of this site alters its interaction with sequestosome 1 (SQSTM1), and targets this isoform to myofibrils, while other isoforms form cytoplasmic aggregates. [provided by RefSeq, Aug 2015]
FHOD3 Gene-Disease associations (from GenCC):
  • cardiomyopathy, familial hypertrophic, 28
    Inheritance: AD Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae), Ambry Genetics
  • hypertrophic cardiomyopathy
    Inheritance: AD Classification: MODERATE Submitted by: Illumina

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -12 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BA1
GnomAd4 highest subpopulation (SAS) allele frequency at 95% confidence interval = 0.211 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
FHOD3NM_001281740.3 linkc.511+27649C>T intron_variant Intron 5 of 28 ENST00000590592.6 NP_001268669.1 Q2V2M9-4

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
FHOD3ENST00000590592.6 linkc.511+27649C>T intron_variant Intron 5 of 28 1 NM_001281740.3 ENSP00000466937.1 Q2V2M9-4
FHOD3ENST00000257209.8 linkc.511+27649C>T intron_variant Intron 5 of 24 1 ENSP00000257209.3 Q2V2M9-3
FHOD3ENST00000359247.8 linkc.511+27649C>T intron_variant Intron 5 of 23 1 ENSP00000352186.3 Q2V2M9-1
FHOD3ENST00000589114.5 linkn.630+27649C>T intron_variant Intron 5 of 13 2

Frequencies

GnomAD3 genomes
AF:
0.0658
AC:
10006
AN:
152110
Hom.:
526
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0289
Gnomad AMI
AF:
0.0703
Gnomad AMR
AF:
0.139
Gnomad ASJ
AF:
0.0193
Gnomad EAS
AF:
0.0508
Gnomad SAS
AF:
0.223
Gnomad FIN
AF:
0.0425
Gnomad MID
AF:
0.0475
Gnomad NFE
AF:
0.0682
Gnomad OTH
AF:
0.0541
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome
AF:
0.0658
AC:
10010
AN:
152228
Hom.:
526
Cov.:
32
AF XY:
0.0686
AC XY:
5106
AN XY:
74434
show subpopulations
African (AFR)
AF:
0.0289
AC:
1202
AN:
41534
American (AMR)
AF:
0.139
AC:
2127
AN:
15296
Ashkenazi Jewish (ASJ)
AF:
0.0193
AC:
67
AN:
3472
East Asian (EAS)
AF:
0.0511
AC:
265
AN:
5182
South Asian (SAS)
AF:
0.222
AC:
1068
AN:
4820
European-Finnish (FIN)
AF:
0.0425
AC:
451
AN:
10604
Middle Eastern (MID)
AF:
0.0442
AC:
13
AN:
294
European-Non Finnish (NFE)
AF:
0.0682
AC:
4635
AN:
68006
Other (OTH)
AF:
0.0559
AC:
118
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
462
924
1385
1847
2309
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
128
256
384
512
640
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0766
Hom.:
120
Bravo
AF:
0.0671
Asia WGS
AF:
0.120
AC:
416
AN:
3478

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.54
CADD
Benign
13
DANN
Benign
0.60
PhyloP100
0.36
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10502661; hg19: chr18-34120155; API